Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: Utilization of microdissection and polymerase chain reaction in archival tissues

Diagnostic Cytopathology

Volumn 24, Issue 5, 2001, Pages 328-332

  Simsir, Aylin ^a   Palacios, Diana ^a   Marston Linehan, W ^a   Merino, Maria J ^a   Abati, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CHROMOSOME 3P; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; METASTASIS; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; CHROMOSOMES, HUMAN, PAIR 3; DIAGNOSIS, DIFFERENTIAL; DISSECTION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LIGASES; LOSS OF HETEROZYGOSITY; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROTEINS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0035002922     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.1070     Document Type: Article

References (20)

1. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome
2. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas
3. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and Her-2/neu gene amplification
4. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas
5. Mapping of chromosome 3p deletions in human epithelial ovarian tumors
6. Identification of the von Hippel-Lindau disease tumor suppressor gene
7. Fine needle aspiration of metastatic clear cell carcinoma of the kidney
8. Mutations of the VHL tumour suppressor gene in renal cell carcinoma
9. Utilization of molecular genetics in the differentiation between adenomas and carcinomas
10. Utilization of microdissection and the PCR for the diagnosis of adrenal cortical carcinoma in FNA cytology
11. Von Hippel-Lindau gene deletion detected in microdissected sporadic human colon carcinoma specimens
12. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in gonadal tumors
13. Deletion mapping of chromosome 3p in female genital tract malignancies using microstaellite polymorphism
14. Frequent microsatellite instability in epithelial borderline ovarian tumors
15. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction
16. Detection of heterozygosity loss on microdissected fine needle aspiration specimens of breast carcinoma
17. Suppression of growth of renal cell carcinoma cells by the von Hippel-Lindau tumor suppressor gene
18. Von Hippel-Lindau disease: Clinical review and molecular genetics
19. Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer
20. Clear cell tumors of unknown nature and origin: A systematic approach to diagnosis